Hall et al., Cell Metabolism 2015
Side Effects of DSIP DSIP is still considered an experimental peptide, and its safety profile has not been comprehensively established
More recently Pfizer has reported development of a humanized GHR monoclonal antagonist antibody (RN172), which blocked GH signaling in vitro and reduced IGF1 production in monkeys following a single-intravenous injection
Here, though, we again run into the issue of your body not being able to absorb the majority of external glutathione just like with supplements
The FDA reclassified key peptides, including BPC-157 and Thymosin Alpha-1, back to Category 1, making them legally available again through licensed compounding pharmacies
This is where a therapy like MOTS-c becomes relevant to the conversation